Tower View Wealth Management’s CVS Health CVS Stock Holding History

Tower View Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-292	Closed	-$20K	–	181
2023 Q2	$20K	Sell	292 -217	-43%	-$15.4K	0.01%	100
2023 Q1	$38K	Buy	509 +4	+0.8%	+$335	0.03%	86
2022 Q4	$47K	Buy	505 +2	+0.4%	+$193	0.03%	83
2022 Q3	$48K	Buy	503 +3	+0.6%	+$297	0.04%	80
2022 Q2	$46K	Hold	500	–	–	0.03%	80
2022 Q1	$51K	Hold	500	–	–	0.03%	102
2021 Q4	$52K	Hold	500	–	–	0.03%	102
2021 Q3	$42K	Buy	+500	New	+$41.9K	0.02%	108
2018 Q4	–	Sell	-202	Closed	-$16K	–	146
2018 Q3	$16K	Hold	202	–	–	0.01%	117
2018 Q2	$13K	Hold	202	–	–	0.01%	114
2018 Q1	$13K	Hold	202	–	–	0.01%	113
2017 Q4	$15K	Buy	+202	New	+$14.7K	0.01%	116

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tower View Wealth Management's CVS Position: Q3 2023 in Review

Tower View Wealth Management sold out of CVS Health (CVS) in Q3 2023, closing a stake of 292 shares — an estimated $20K sold.

Tower View Wealth Management first reported a position in CVS in Q4 2017 and held it in 12 quarters. The position peaked at $52K in Q4 2021. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

Tower View Wealth Management reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
Tower View Wealth Management sold 292 CVS Health shares in Q3 2023, an estimated $20K.
Tower View Wealth Management first reported a position in CVS Health in Q4 2017 and held it in 12 quarters.
Tower View Wealth Management's CVS Health position peaked at $52K in Q4 2021.
2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Tower View Wealth Management's 13F filing for Q3 2023, filed 31 Oct 2023.